352 related articles for article (PubMed ID: 29801989)
1. Ten-year survival in glioblastoma. A systematic review.
Tykocki T; Eltayeb M
J Clin Neurosci; 2018 Aug; 54():7-13. PubMed ID: 29801989
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of resection extent for patients with glioblastoma multiforme: a meta-analysis.
Li XZ; Li YB; Cao Y; Li PL; Liang B; Sun JD; Feng ES
J Neurosurg Sci; 2017 Dec; 61(6):631-639. PubMed ID: 26824196
[TBL] [Abstract][Full Text] [Related]
3. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
[TBL] [Abstract][Full Text] [Related]
4. Is the long-term survival of patients with intracranial glioblastoma multiforme overstated?
McLendon RE; Halperin EC
Cancer; 2003 Oct; 98(8):1745-8. PubMed ID: 14534892
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of overall survival in pediatric primary glioblastoma multiforme of the spinal cord.
Konar SK; Bir SC; Maiti TK; Nanda A
J Neurosurg Pediatr; 2017 Feb; 19(2):239-248. PubMed ID: 27813458
[TBL] [Abstract][Full Text] [Related]
6. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
7. Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.
Botros D; Dux H; Price C; Khalafallah AM; Mukherjee D
Neurosurg Rev; 2021 Jun; 44(3):1259-1271. PubMed ID: 32533385
[TBL] [Abstract][Full Text] [Related]
8. Association of the Extent of Resection With Survival in Glioblastoma: A Systematic Review and Meta-analysis.
Brown TJ; Brennan MC; Li M; Church EW; Brandmeir NJ; Rakszawski KL; Patel AS; Rizk EB; Suki D; Sawaya R; Glantz M
JAMA Oncol; 2016 Nov; 2(11):1460-1469. PubMed ID: 27310651
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Survival Outcomes Between Partial Resection and Biopsy for Primary Glioblastoma: A Propensity Score-Matched Study.
Byun J; Kim YH; Nam SJ; Park JE; Cho YH; Kim HS; Hong SH; Kim JH; Kim SJ; Kim CJ
World Neurosurg; 2019 Jan; 121():e858-e866. PubMed ID: 30315970
[TBL] [Abstract][Full Text] [Related]
10. MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.
Kim YS; Kim SH; Cho J; Kim JW; Chang JH; Kim DS; Lee KS; Suh CO
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):661-7. PubMed ID: 22414280
[TBL] [Abstract][Full Text] [Related]
11. Contribution of low-molecular weight heparin addition to concomitant chemoradiotherapy in the treatment of glioblastoma multiforme.
Zincircioglu SB; Kaplan MA; Isikdogan A; Cil T; Karadayi B; Dirier A; Kucukoner M; Inal A; Yildiz I; Aggil F; Donmez O; Urakci Z; Pekkolay Z; Firat U
J BUON; 2012; 17(1):124-7. PubMed ID: 22517705
[TBL] [Abstract][Full Text] [Related]
12. Do Long-Term Survivor Primary Glioblastoma Patients Harbor IDH1 Mutations?
Sarmiento JM; Mukherjee D; Black KL; Fan X; Hu JL; Nuno MA; Patil CG
J Neurol Surg A Cent Eur Neurosurg; 2016 May; 77(3):195-200. PubMed ID: 26935296
[TBL] [Abstract][Full Text] [Related]
13. Pre-Operative Perfusion Skewness and Kurtosis Are Potential Predictors of Progression-Free Survival after Partial Resection of Newly Diagnosed Glioblastoma.
Paik W; Kim HS; Choi CG; Kim SJ
Korean J Radiol; 2016; 17(1):117-26. PubMed ID: 26798224
[TBL] [Abstract][Full Text] [Related]
14. Impact of extent of resection and recurrent surgery on clinical outcome and overall survival in a consecutive series of 170 patients for glioblastoma in intraoperative high field magnetic resonance imaging.
Coburger J; Wirtz CR; König RW
J Neurosurg Sci; 2017 Jun; 61(3):233-244. PubMed ID: 26149222
[TBL] [Abstract][Full Text] [Related]
15. The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.
Lu VM; Jue TR; McDonald KL; Rovin RA
World Neurosurg; 2018 Jul; 115():453-459.e3. PubMed ID: 29654958
[TBL] [Abstract][Full Text] [Related]
16. Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma.
Randolph DM; McTyre ER; Paulsson AK; Holmes JA; Hinson WH; Lesser GJ; Strowd R; Lo HW; Laxton AW; Tatter SB; Debinski W; Chan MD
Clin Neurol Neurosurg; 2016 Dec; 151():73-78. PubMed ID: 27816029
[TBL] [Abstract][Full Text] [Related]
17. The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma.
Neidert MC; Hostettler IC; Burkhardt JK; Mohme M; Held U; Kofmehl R; Eisele G; Woernle CM; Regli L; Bozinov O
Neurosurg Rev; 2016 Jul; 39(3):401-9. PubMed ID: 26860420
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone administration during definitive radiation and temozolomide renders a poor prognosis in a retrospective analysis of newly diagnosed glioblastoma patients.
Shields LB; Shelton BJ; Shearer AJ; Chen L; Sun DA; Parsons S; Bourne TD; LaRocca R; Spalding AC
Radiat Oncol; 2015 Oct; 10():222. PubMed ID: 26520780
[TBL] [Abstract][Full Text] [Related]
19. Aggressive repeat surgery for focally recurrent primary glioblastoma: outcomes and theoretical framework.
Sughrue ME; Sheean T; Bonney PA; Maurer AJ; Teo C
Neurosurg Focus; 2015 Mar; 38(3):E11. PubMed ID: 25727220
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of c-Met is Associated with Poor Prognosis in Glioblastoma Multiforme: A Systematic Review and Meta-Analyses.
Anton J; Sudibio S; Handoko H; Permata TBM; Kodrat H; Nuryadi E; Sofyan H; Susanto E; Mulyadi R; Aman RA; Gondhowiardjo S
Asian Pac J Cancer Prev; 2021 Oct; 22(10):3075-3080. PubMed ID: 34710981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]